The biological mechanisms that govern human aging have long remained an enigma, characterized by a gradual, systemic decline in organ…
Read More
Cornell University Researchers Unlock a Paradigm Shift in Nonhormonal Male Contraception Through Groundbreaking Meiotic Targeting Study
For decades, the global landscape of human contraception has placed an asymmetric burden of responsibility upon women, leaving men with…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions worldwide, the diagnosis of actinic keratosis (AK) marks the beginning of a challenging journey to prevent skin cancer.…
Read More
Cornell University Researchers Develop Breakthrough Reversible Nonhormonal Male Contraceptive Method Targeting Meiosis
In a significant advancement for reproductive medicine, scientists at Cornell University have identified a viable pathway toward a safe, reversible,…
Read More
Bocunebart’s PACAP-Targeting Mechanism Positions it as a Potential First-in-Class Therapy in a Thin Pipeline of Novel Late-Stage Candidates
New Data Unveiled for Bocunebart, a Promising Migraine Preventive Targeting a Novel Pathway Munich, Germany – June 29, 2026 –…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions worldwide, the diagnosis of actinic keratoses (AK) initiates a challenging journey to prevent the progression to skin cancer.…
Read More
DNA Aptamers Offer a Promising New Frontier in Identifying and Targeting Senescent Cells for Aging and Disease Research
One of the most significant hurdles in unraveling the complexities of aging and a spectrum of diseases lies in the…
Read More
Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP
Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
Rubedo Life Sciences, an AI-driven biotech startup focused on longevity, has announced positive preliminary results from its Phase 1b/2a study…
Read More
Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis
In a landmark achievement for reproductive science, researchers at Cornell University have announced a significant advancement in the pursuit of…
Read More
